Blood Cancer

Mantle Cell Lymphoma is an aggressive type of blood cancer that develops in the outer part of the lymph node, an essential part of the immune system.⁴ Affecting only 1 in 100,000 people, MCL is a very rare cancer.⁵

Amyloidosis occurs when the body begins to make a protein differently than it did before and is no longer able to absorb that protein.⁶ There are several types of Amyloidosis, the four most common of which are: Amyloid light-chain (AL) Amyloidosis, Amyloid A (AA) Amyloidosis, Hereditary Amyloidosis, and Wild-type Amyloidosis.⁷

Chronic Lymphocytic Leukaemia is a slow-growing cancer of the blood and bone marrow, which results in incompetent, small white blood cells that compromise the immune system. CLL is one of the most common types of leukaemia in Western countries, accounting for 25% of all diagnoses.⁷ There are instances in which CLL is used as an overarching term that includes Small Lymphocytic Lymphoma (SLL) because they are both nearly the same disease, however CLL is commonly detected in the blood and bone marrow, whereas SLL is primarily detected in the lymph nodes.

Marginal Zone Lymphoma is a slow-growing blood cancer that develops in the marginal zones of the lymphatic tissue, a key part of our immune system.⁸ It’s a rare cancer that has three subtypes: Mucosa-Associated Lymphoid Tissue (MALT), Nodal Marginal Zone B-cell Lymphoma (NMZL) and Splenic Marginal Zone B-cell Lymphoma (SMZL).

Myelodysplastic Syndromes are a group of rare, slow-growing blood disorders in which blood cells are misprinted, making them unable to do their job properly.⁹ MDS subtypes are categorized by the specific type of blood cell affected and vary in rarity.¹⁰